Eli Lilly and

NYSE: LLY · Real-Time Price · USD
702.09
17.66 (2.58%)
At close: Aug 15, 2025, 3:59 PM
702.39
0.04%
After-hours: Aug 15, 2025, 06:25 PM EDT

Eli Lilly and Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
15.56B 12.73B 13.53B 11.44B 11.3B 8.77B 9.35B 9.5B 8.31B 6.96B 7.3B 6.94B 6.49B 7.81B 8B 6.77B 6.74B 6.81B
Cost of Revenue
2.45B 2.22B 2.4B 2.17B 2.17B 1.67B 1.79B 1.86B 1.81B 1.63B 1.55B 1.58B 1.43B 2.07B 2.05B 1.43B 1.95B 1.88B
Gross Profit
13.11B 10.5B 11.13B 9.27B 9.13B 7.09B 7.57B 7.64B 6.5B 5.33B 5.75B 5.36B 5.06B 5.74B 5.95B 5.34B 4.79B 4.93B
Operating Income
7.13B 5.41B 5.8B 4.55B 4.42B 2.74B 3.19B 3.54B 2.34B 1.71B 2.21B 2.04B 1.74B 2.66B 2.47B 2.13B 1.52B 1.75B
Interest Income
40M 48.3M 44.3M 47.8M 37.3M 45.8M 44.5M 48.9M 46M 34.2M 25.5M 20.1M 10.2M 7M 7.4M 7M 5.4M 5.5M
Pretax Income
6.78B 3.46B 5.04B 1.59B 3.52B 2.54B 2.51B 427.2M 2.09B 1.53B 2.1B 1.57B 1.09B 2.05B 1.84B 1.25B 1.59B 1.48B
Net Income
5.66B 2.76B 4.41B 970.3M 2.97B 2.24B 2.19B -57.4M 1.76B 1.34B 1.94B 1.45B 952.5M 1.9B 1.73B 1.11B 1.39B 1.36B
Selling & General & Admin
2.65B 2.36B 2.31B 1.98B 2B 1.84B 1.81B 1.69B 1.81B 1.63B 1.55B 1.52B 1.53B 1.46B 1.52B 1.51B 1.61B 1.5B
Research & Development
3.34B 2.73B 3.02B 2.73B 2.71B 2.52B 2.56B 2.41B 2.36B 1.99B 2B 1.8B 1.78B 1.61B 1.96B 1.71B 1.66B 1.67B
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
5.98B 5.1B 5.33B 4.72B 4.71B 4.36B 4.37B 4.1B 4.17B 3.62B 3.55B 3.32B 3.31B 3.07B 3.48B 3.21B 3.27B 3.17B
Interest Expense
249M 243.7M 224.7M 192.7M 183.6M 179.6M 138.2M 124.6M 120.3M 102.8M 84M 81.5M 81.2M 84.9M 81.4M 83.6M 86.9M 87.8M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
8.43B 7.32B 7.74B 6.89B 6.88B 6.03B 6.16B 5.96B 5.97B 5.25B 5.09B 4.9B 4.74B 5.15B 5.53B 4.64B 5.22B 5.05B
Income Tax Expense
1.12B 696.8M 628.9M 618.1M 550.2M 293.2M 319.1M 484.6M 325.7M 184.8M 158.7M 113.8M 138.4M 150.7M 113.8M 135.2M 203.7M 121.1M
Shares Outstanding (Basic)
897.9M 897.99M 897.54M 901M 900.9M 900.8M 899.38M 949.3M 949.29M 949.27M 950.18M 900.7M 900.3M 950.61M 953.65M 956.59M 907.3M 959.48M
Shares Outstanding (Diluted)
899.79M 900.6M 903.16M 905M 904.2M 903.8M 903.98M 949.3M 949.29M 949.27M 950.18M 903.8M 902.9M 950.61M 953.65M 956.59M 910.4M 959.48M
EPS (Basic)
6.30 3.07 4.91 1.08 3.29 2.49 2.43 -0.06 1.86 1.42 2.04 1.61 1.06 2.00 1.81 1.16 1.53 1.41
EPS (Diluted)
6.29 3.06 4.88 1.07 3.28 2.48 2.42 -0.06 1.86 1.42 2.04 1.61 1.05 2.00 1.81 1.16 1.53 1.41
EBITDA
7.5B 4.16B 5.75B 2.25B 4.12B 3.12B 3.03B 962.8M 2.58B 1.99B 2.56B 2.01B 1.52B 2.57B 2.37B 1.71B 2.05B 1.91B
EBIT
7.03B 3.7B 5.26B 1.78B 3.7B 2.72B 2.65B 551.8M 2.21B 1.63B 2.18B 1.65B 1.17B 2.14B 1.92B 1.33B 1.68B 1.56B
Depreciation & Amortization
478.5M 462.8M 484.8M 466.8M 414.4M 400.6M 387.7M 411M 366.3M 362.3M 375M 362.9M 348.9M 435.7M 445.7M 382.3M 369.3M 350.3M